Salomon & Ludwin’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.96K Sell
200
-2
-1% -$22 ﹤0.01% 1936
2025
Q4
$2.01K Sell
202
-3
-1% -$37 ﹤0.01% 1997
2025
Q3
$3.24K Sell
205
-10
-5% -$146 ﹤0.01% 1884
2025
Q2
$3.17K Hold
215
﹤0.01% 611
2025
Q1
$5.17K Hold
215
﹤0.01% 514
2024
Q4
$8.03K Hold
215
﹤0.01% 468
2024
Q3
$10.7K Hold
215
﹤0.01% 445
2024
Q2
$7.46K Hold
215
﹤0.01% 484
2024
Q1
$11.8K Hold
215
﹤0.01% 539
2023
Q4
$5.59K Hold
215
﹤0.01% 570
2023
Q3
$5.59K Buy
+215
New +$4.47K ﹤0.01% 568

Other funds holding BHVN

Salomon & Ludwin's BHVN Position: Q1 2026 in Review

Salomon & Ludwin reduced its Biohaven (BHVN) stake by 0.99% in Q1 2026, selling an estimated $22 and leaving 200 shares worth $1.96K. The position accounts for ﹤0.01% of the portfolio, ranked #1936.

Salomon & Ludwin first reported a position in BHVN in Q3 2023 and has held it in 11 quarters since. The position peaked at $11.8K in Q1 2024. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Salomon & Ludwin held 200 shares of Biohaven worth $1.96K as of Q1 2026.
  • Salomon & Ludwin sold 2 Biohaven shares in Q1 2026, an estimated $22.
  • Biohaven made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #1936 holding.
  • Salomon & Ludwin first reported a position in Biohaven in Q3 2023 and has held it in 11 quarters since.
  • Salomon & Ludwin's Biohaven position peaked at $11.8K in Q1 2024.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.